1998Fundamental and Clinical PharmacologyRequires access

Enhancement of the vasodepressor response to adenosine by nicorandil in rats: comparison with cromakalim

Keiji Saito, Kazushige Sakai

Open publisher page 16 citations

Abstract

The effect of nicorandil on systemic blood pressure (SBP) and heart rate (HR) responses to adenosine was compared with that of cromakalim, an adenosine triphosphate (ATP)-sensitive K+ channel opener, in anesthetized rats. Intravenous (i.v.) adenosine in doses of 1-100 micrograms/kg elicited dose-dependent decreases in SBP, accompanied by decreases in HR. Potentiation of adenosine action by i.v. infusion of either nicorandil (10 or 30 micrograms/kg per min) or cromakalim (0.1 microgram/kg per min) occurred in all of the animals tested. After i.v. treatment with glibenclamide (20 mg/kg), an ATP-sensitive K+ channel blocker, not only adenosine action but also the enhancement of adenosine action by nicorandil and cromakalim were significantly attenuated. The present result indicates that the enhancement of the adenosine action by nicorandil and cromakalim appears to occur at least partly through ATP-sensitive K+ channel activation.

About this research paper

What this paper is about

The effect of nicorandil on systemic blood pressure (SBP) and heart rate (HR) responses to adenosine was compared with that of cromakalim, an adenosine triphosphate (ATP)-sensitive K+ channel opener, in anesthetized rats. Intravenous (i.v.) adenosine in doses of 1-100 micrograms/kg elicited dose-dependent decreases in SBP, accompanied by decreases in HR. Potentiation of adenosine action by i.v. infusion of either nicorandil (10 or 30 micrograms/kg per min) or cromakalim (0.1 microgram/kg per min) occurred in all of the animals tested. After i.v. treatment with glibenclamide (20 mg/kg), an ATP-sensitive K+ channel blocker, not only adenosine action but also the enhancement of adenosine action by nicorandil and cromakalim were significantly attenuated. The present result indicates that the enhancement of the adenosine action by nicorandil and cromakalim appears to occur at least partly through ATP-sensitive K+ channel activation.

Why it matters

OpenAlex reports 16 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The effect of nicorandil on systemic blood pressure (SBP) and heart rate (HR) responses to adenosine was compared with that of cromakalim, an adenosine triphosphate (ATP)-sensitive K+ channel opener, in anesthetized rats. Intravenous (i.v.) adenosine in doses of 1-100 micrograms/kg elicited dose-dependent decreases in SBP, accompanied by decreases in HR. Potentiation of adenosine action by i.v. infusion of either nicorandil (10 or 30 micrograms/kg per min) or cromakalim (0.1 microgram/kg per min) occurred in all of the animals tested. After i.v. treatment with glibenclamide (20 mg/kg), an ATP-sensitive K+ channel blocker, not only adenosine action but also the enhancement of adenosine action by nicorandil and cromakalim were significantly attenuated. The present result indicates that the enhancement of the adenosine action by nicorandil and cromakalim appears to occur at least partly through ATP-sensitive K+ channel activation.

Key concepts: Nicorandil, Cromakalim, Adenosine, Glibenclamide, Internal medicine, Chemistry, Potassium channel opener, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Enhancement of the vasodepressor response to adenosine by nicorandil in rats: comparison with cromakalim — Research Paper | ScholarLens